Buy Now
Veterinary Diagnostics Market Size, Share, Growth & Industry Analysis, By Type (Consumables, Reagents & Kits), By Animal Type (Cattle, Canine, Feline, Caprine, Porcine, Ovine, Avian, Others), By Testing Type, By Disease, By End Use, and Regional Analysis, 2024-2031
Pages: 230 | Base Year: 2023 | Release: February 2025 | Author: Versha V.
Veterinary diagnostics involves the use of various tools and technologies, such as laboratory tests, imaging (X-rays, ultrasound, MRI), and clinical exams, to identify health conditions, diseases, and injuries in animals.
It helps veterinarians assess an animal's health and make informed decisions about treatment and care through the analysis of biological samples like blood, urine, and tissues.
The global veterinary diagnostics market size was valued at USD 5.91 billion in 2023 and is projected to grow from USD 6.31 billion in 2024 to USD 10.30 billion by 2031, exhibiting a CAGR of 7.23% during the forecast period.
The market is expanding, due to the increasing pet ownership and surging investment in pet welfare. Advancements in diagnostics, rising incidence of animal diseases, and increasing medication rate are driving the market.
Ongoing advancements in veterinary diagnostic technologies, including molecular diagnostics, imaging modalities, and point-of-care testing, have enhanced the accuracy and efficiency of animal disease diagnosis.
Major companies operating in the veterinary diagnostics market are Agrolabo S.p.A., Antech Diagnostics, Inc., Embark Veterinary, Inc., Esaote SpA, FUJIFILM Corporation, IDEXX Laboratories, Inc., Innovative Diagnostics SAS, Thermo Fisher Scientific Inc., Virbac, Zoetis Services LLC, Heska Corporation, Avante Animal Health, Randox Laboratories Ltd., Biomerieux, and Meridian Bioscience.
Ongoing advancements in veterinary diagnostic technologies, including molecular diagnostics, imaging techniques, and point-of-care testing, have enhanced the ability to diagnose animal diseases. These innovations improve diagnostic accuracy and speed, driving the market as veterinarians and pet owners increasingly seek cutting-edge solutions for comprehensive healthcare.
The development and adoption of point-of-care diagnostic tools, which deliver rapid, on-site results, spurred market growth. These tools facilitate prompt decision-making in veterinary practices, enabling timely and effective treatment, thereby improving animal health outcomes. Companies in the market are collaborating in terms of diagnosis of veterinary diseases.
Market Driver
"Rising Prevalence of Zoonotic Diseases"
The rising prevalence of zoonotic diseases is propelling the veterinary diagnostics market. The World Health Organization (WHO) estimates that approximately 60% of emerging infectious diseases originate from animals, emphasizing the crucial need for robust animal health monitoring to protect public health.
Zoonotic diseases, such as rabies, Lyme disease, brucella, and salmonella, highlight the significant risks associated with animal-to-human transmission, spurring the demand for advanced veterinary diagnostics.
Market Challenge
"High Costs Associated with Diagnostic Tests"
The high costs associated with diagnostic tests pose a significant challenge to the market. Advanced diagnostic tools such as PCR testing, imaging modalities (MRI, CT scans), and specialized blood tests require sophisticated equipment and expertise, leading to increased operational costs for veterinary clinics and laboratories.
These high expenses can be a burden for pet owners, livestock farmers, and even veterinary service providers, potentially limiting the accessibility and adoption of crucial diagnostic procedures.
Solutions such as insurance coverage for pet healthcare and the development of cost-effective point-of-care diagnostic tools can help reduce financial strain. Furthermore, technological advancements, including AI-driven diagnostics and portable testing devices, can enhance efficiency and drive cost reductions over time.
Fostering strategic collaborations between veterinary institutions, diagnostic companies, and research organizations can further accelerate innovation and improve affordability within the market.
Market Trend
"Favorable Government Support to Accelerate Adoption"
Favorable government support and heightened awareness among livestock owners drive the demand for animal disease diagnostic tests and kits, which is expected to accelerate the market growth.
Educational programs and awareness campaigns led by government entities can also help veterinarians understand the benefits of modern diagnostic technologies, ensuring their widespread adoption.
Additionally, select government-funded laboratories are advancing their capabilities for early disease detection. Financial incentives, such as subsidies, grants, and tax breaks for veterinary clinics and diagnostic labs, can reduce the financial burden on businesses, enabling them to access and implement advanced diagnostic solutions.
Segmentation |
Details |
By Type |
Consumables, Reagents & Kits, Instruments & Devices |
By Animal Type |
Cattle, Canine, Feline, Caprine, Porcine, Ovine, Avian, Others |
By Testing Type |
Analytical Services, Diagnostics Imaging, Bacteriology, Pathology, Molecular Diagnostics, Parasitology, Immunoassays, Serology, Virology |
By Disease |
Infectious, Non-infectious, Hereditary, Congenital and Acquired Diseases, General Ailments, Structural and Functional Diseases |
By End Use |
Laboratories, Veterinary Hospitals and Clinics, Point-Of-Care/In-House Testing, Research Institutes and Universities |
By Region |
North America: U.S., Canada, Mexico |
Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe |
|
Asia Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia Pacific |
|
Middle East & Africa: Turkey, UAE, Saudi Arabia, South Africa, Rest of Middle East & Africa |
|
South America: Brazil, Argentina, Rest of South America |
Market Segmentation:
Based on region, the market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
North America accounted for around 36.56% share of the veterinary diagnostics market in 2023, with a valuation of USD 2.16 billion. Increasing pet ownership and advancements in diagnostics technologies are driving the market in the region. The growing awareness of animal health and welfare has driven pet owners to pursue enhanced medical care for their pets.
The veterinary diagnostics industry is being revolutionized by advanced technologies, including molecular diagnostic testing, imaging, and rapid diagnostics. These innovations enable the timely and precise identification of animal diseases, leading to better treatment outcomes. Companies in the market are launching testing and diagnostics kits to cure animal diseases.
The prevalence of veterinary diseases has surged in the region, with concerns rising over the growing incidence of conditions such as rabies, Lyme disease, and heartworm.
This has driven the demand for diagnostic and testing services for animals. Veterinary clinics and animal hospitals are making significant investments in advanced diagnostic equipment to ensure the delivery of reliable and accurate test results for pet owners.
The veterinary diagnostics market in Asia Pacific is poised for significant growth at a robust CAGR of 8.36% over the forecast period. The increasing demand for enhanced animal healthcare and supporting government initiatives are fostering the growth of the market in the region.
The rising awareness among pet owners and livestock farmers regarding the importance of early disease detection and preventive care led to a surge in the adoption of diagnostic technologies. Furthermore, the expanding livestock industry, coupled with the growing prevalence of zoonotic diseases, accelerated the need for efficient veterinary diagnostic tools.
Governments across the region are actively promoting animal health initiatives through funding, policy frameworks, and collaborations with private sector players, and product launches fostering innovation and accessibility of diagnostic solutions.
The veterinary diagnostics market is characterized by a large number of participants, including both established corporations and rising organizations. Key players in the market are making substantial investments in research and development (R&D) to enhance their product portfolios, fostering the market growth.
Companies are engaging in strategic initiatives to strengthen their market presence, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and expanding their presence and collaborations with other organizations.
The veterinary diagnostics sector must focus on delivering cost-effective solutions to remain competitive and thrive in an evolving market landscape.
Recent Developments (Partnership/New Product Launch)
Frequently Asked Questions